Search results
We regulate health products to meet standards of safety, quality and efficacy. HSA is the national authority regulating health products; managing the national blood bank, transfusion medicine and forensic medicine expertise; and providing critical forensic and analytical laboratory services.
- E-services
Before you can proceed to apply for eGIRO, you need to have...
- Medical Devices
Before you continue: You are encouraged to check if your...
- Therapeutic Products
You will need to register your therapeutic products and...
- Cosmetic Products
We regulate cosmetic products in Singapore to ensure that,...
- Contact Us
Singapore 169078. View map Telephone (65) 6213 0838...
- Blood Donation
Blood transfusion. Understand what blood transfusion entails...
- Applied Sciences
About HSA. CEO's message. Vision, mission and values. Board...
- Report adverse events
You may access the HSA Adverse Event Online Database for...
- E-services
About HSA. Our mission is to wisely regulate health products, serve the administration of justice, secure the nation's blood supply and safeguard public health. What we do. Applied sciences. We serve the administration of justice with the use of forensic medicine, forensic science and analytical chemistry testing. Blood services.
Oct 16, 2019 · This search enables you to get a listing of all registered Therapeutic Products in Singapore and their current approved Package Inserts (PIs)/Patient Information Leaftlets (PILs). Note: Not all PIs and PILs are currently available online
Find the latest updates and guidance from HSA on COVID-19 vaccines, medical devices, treatments and prevention measures. Learn about HSA's regulatory actions, safety reviews, collaborations and consumer advisories on COVID-19 related products and services.
- Rolling Data Submission For Speedier Evaluation
- Continuous Review of Data
- Transition to Full Product Registration
4 Using PSAR, HSA can start evaluating new vaccines, medicines and medical devices from the early stages of clinical studies, as and when real-time data is submitted by companies on a “rolling”, or staggered basis, instead of waiting for the full data set to be submitted before starting our evaluation. This gives HSA more time to review the submitt...
6 As a condition for the interim authorisation under PSAR, companies must continue submitting longer term follow up data to HSA to assure the continued effectiveness and safety of the vaccine. HSA will actively review the data to ensure that the benefits of the vaccine, medicine or medical device continue to outweigh the known risks. HSA may termin...
7 When sufficient data is available for full registration, companies will be required to file an application to transition the status of the product from PSAR interim authorisation to full registration. 8 For more technical information on the application for PSAR, refer to: https://www.hsa.gov.sg/therapeutic-products/register/special-access-routes/...
http://www.hsa.gov.sg. The Health Sciences Authority is the national authority regulating health products; managing the national blood bank, transfusion medicine and forensic medicine expertise; and providing critical forensic and analytical laboratory services.
HSA SHARE is a web portal that allows users to search and view the approved health products in Singapore, such as therapeutic products, medical devices, and clinical trials. Users can also access various e-services and guidance documents related to the regulatory process and safety reporting.
